| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Penumbra IncPEN | $309.26 | Strong Buy | $359.00 | +16.08% | 18 hours ago | |
Analyst RankingTop 5% #233 out of 5156 analysts Average Return+32.73% Win Rate69%47 out of 68 Risk vs RewardPoor Good Analyst ColorCanaccord Genuity's Jason Mills raised their price target on Penumbra (NYSE: PEN) by 1.1% from $355 to $359 on 2025/12/17. The analyst maintained their Strong Buy rating on the stock. In a 2026 preview note on names in their MedTech portfolio, Mills said they are bullish on the sector. The analyst attributed their enthusiasm to (1) strong underlying demand from an aging population, (2) a focus on acute healthcare needs, (3) the healthy pace of M&A, and (4) a market that is receptive to IPOs. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to ? Sign In | ||||||